Danaher Corporation (DHR)
NYSE·Healthcare·Medical - Diagnostics & Research
$212.49
+1.94%
Mkt Cap $144.11B
Analyst Ratings
Buy
14
Hold
4
Sell
0
Price Target (59 analysts)
$223.77
Range $195.00 – $250.00
Implied Upside
+5.3%
Consensus $223.77 vs current $212.49